Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 93

1.

Evaluation of the possible influence of trailing and paradoxical effects on the clinical outcome of patients with candidemia.

Rueda C, Puig-Asensio M, Guinea J, Almirante B, Cuenca-Estrella M, Zaragoza O; CANDIPOP Project from GEIH-GEMICOMED (SEIMC) and REIPI.

Clin Microbiol Infect. 2017 Jan;23(1):49.e1-49.e8. doi: 10.1016/j.cmi.2016.09.016. Epub 2016 Sep 24.

2.

A multi-centric Study of Candida bloodstream infection in Lima-Callao, Peru: Species distribution, antifungal resistance and clinical outcomes.

Rodriguez L, Bustamante B, Huaroto L, Agurto C, Illescas R, Ramirez R, Diaz A, Hidalgo J.

PLoS One. 2017 Apr 18;12(4):e0175172. doi: 10.1371/journal.pone.0175172. eCollection 2017.

3.

Candida and candidaemia. Susceptibility and epidemiology.

Arendrup MC.

Dan Med J. 2013 Nov;60(11):B4698. Review.

PMID:
24192246
4.

Initial use of echinocandins does not negatively influence outcome in Candida parapsilosis bloodstream infection: a propensity score analysis.

Fernández-Ruiz M, Aguado JM, Almirante B, Lora-Pablos D, Padilla B, Puig-Asensio M, Montejo M, García-Rodríguez J, Pemán J, Ruiz Pérez de Pipaón M, Cuenca-Estrella M; CANDIPOP Project; GEIH-GEMICOMED (SEIMC); REIPI.

Clin Infect Dis. 2014 May;58(10):1413-21. doi: 10.1093/cid/ciu158. Epub 2014 Mar 18.

PMID:
24642553
5.

Scope and frequency of fluconazole trailing assessed using EUCAST in invasive Candida spp. isolates.

Marcos-Zambrano LJ, Escribano P, Sánchez-Carrillo C, Bouza E, Guinea J.

Med Mycol. 2016 Oct 1;54(7):733-9. doi: 10.1093/mmy/myw033. Epub 2016 May 9.

PMID:
27161788
6.

Impact of therapeutic strategies on the prognosis of candidemia in the ICU.

Puig-Asensio M, Pemán J, Zaragoza R, Garnacho-Montero J, Martín-Mazuelos E, Cuenca-Estrella M, Almirante B; Prospective Population Study on Candidemia in Spain (CANDIPOP) Project; Hospital Infection Study Group (GEIH); Medical Mycology Study Group (GEMICOMED) of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC); Spanish Network for Research in Infectious Diseases.

Crit Care Med. 2014 Jun;42(6):1423-32. doi: 10.1097/CCM.0000000000000221.

PMID:
24557426
7.

Impact of fluconazole susceptibility on the outcome of patients with candidaemia: data from a population-based surveillance.

Fernández-Ruiz M, Guinea J, Lora-Pablos D, Zaragoza Ó, Puig-Asensio M, Almirante B, Cuenca-Estrella M, Aguado JM; CANDIPOP Project; GEIH-GEMICOMED (SEIMC) and REIPI.

Clin Microbiol Infect. 2017 Sep;23(9):672.e1-672.e11. doi: 10.1016/j.cmi.2017.01.014. Epub 2017 Jan 29.

8.

Candida bloodstream infections: comparison of species distribution and resistance to echinocandin and azole antifungal agents in Intensive Care Unit (ICU) and non-ICU settings in the SENTRY Antimicrobial Surveillance Program (2008-2009).

Pfaller MA, Messer SA, Moet GJ, Jones RN, Castanheira M.

Int J Antimicrob Agents. 2011 Jul;38(1):65-9. doi: 10.1016/j.ijantimicag.2011.02.016. Epub 2011 Apr 22.

PMID:
21514797
9.

Recent exposure to caspofungin or fluconazole influences the epidemiology of candidemia: a prospective multicenter study involving 2,441 patients.

Lortholary O, Desnos-Ollivier M, Sitbon K, Fontanet A, Bretagne S, Dromer F; French Mycosis Study Group.

Antimicrob Agents Chemother. 2011 Feb;55(2):532-8. doi: 10.1128/AAC.01128-10. Epub 2010 Nov 15.

10.

Epidemiology, risk factor, species distribution, antifungal resistance and outcome of Candidemia at a single French hospital: a 7-year study.

Tadec L, Talarmin JP, Gastinne T, Bretonnière C, Miegeville M, Le Pape P, Morio F.

Mycoses. 2016 May;59(5):296-303. doi: 10.1111/myc.12470. Epub 2016 Jan 25.

PMID:
26806101
11.

Epidemiology of candidemia and antifungal susceptibility in invasive Candida species in the Asia-Pacific region.

Wang H, Xu YC, Hsueh PR.

Future Microbiol. 2016 Oct;11:1461-1477. Epub 2016 Oct 18. Review.

PMID:
27750452
12.

[Evaluation of PNA-FISH method for direct identification of Candida species in blood culture samples and its potential impact on guidance of antifungal therapy].

Doğan Ö, İnkaya AÇ, Gülmez D, Uzun Ö, Akova M, Arıkan Akdağlı S.

Mikrobiyol Bul. 2016 Oct;50(4):580-589. Turkish.

13.

Antifungal susceptibility of Candida species isolated from patients with candidemia in southern Taiwan, 2007-2012: impact of new antifungal breakpoints.

Chen YC, Kuo SF, Chen FJ, Lee CH.

Mycoses. 2017 Feb;60(2):89-95. doi: 10.1111/myc.12553. Epub 2016 Sep 12.

PMID:
27621210
14.

Candida bloodstream infections: comparison of species distributions and antifungal resistance patterns in community-onset and nosocomial isolates in the SENTRY Antimicrobial Surveillance Program, 2008-2009.

Pfaller MA, Moet GJ, Messer SA, Jones RN, Castanheira M.

Antimicrob Agents Chemother. 2011 Feb;55(2):561-6. doi: 10.1128/AAC.01079-10. Epub 2010 Nov 29.

15.

In vitro susceptibility and molecular characterization of Candida spp. from candidemic patients.

Herkert PF, Gomes RR, Muro MD, Pinheiro RL, Fornari G, Vicente VA, Queiroz-Telles F.

Rev Iberoam Micol. 2015 Oct-Dec;32(4):221-8. doi: 10.1016/j.riam.2014.07.007. Epub 2014 Dec 20.

PMID:
25681153
16.

Surveillance study of species distribution, antifungal susceptibility and mortality of nosocomial candidemia in a tertiary care hospital in China.

Ma CF, Li FQ, Shi LN, Hu YA, Wang Y, Huang M, Kong QQ.

BMC Infect Dis. 2013 Jul 22;13:337. doi: 10.1186/1471-2334-13-337.

17.

Risk factors of mortality and comparative in-vitro efficacy of anidulafungin, caspofungin, and micafungin for candidemia.

Lee SC, Lee CW, Shih HJ, Huang SH, Chiou MJ, See LC.

J Microbiol Immunol Infect. 2014 Jun;47(3):245-53. doi: 10.1016/j.jmii.2013.09.006. Epub 2013 Nov 15.

18.

Antifungal susceptibility testing of a 10-year collection of Candida spp. isolated from patients with candidemia.

Iatta R, Caggiano G, Cuna T, Montagna MT.

J Chemother. 2011 Apr;23(2):92-6.

PMID:
21571625
19.

Nosocomial Bloodstream Infection Due to Candida spp. in China: Species Distribution, Clinical Features, and Outcomes.

Li Y, Du M, Chen LA, Liu Y, Liang Z.

Mycopathologia. 2016 Aug;181(7-8):485-95. doi: 10.1007/s11046-016-9997-3. Epub 2016 Mar 19.

PMID:
26994763
20.

Propensity Score Analysis of the Role of Initial Antifungal Therapy in the Outcome of Candida glabrata Bloodstream Infections.

Puig-Asensio M, Fernández-Ruiz M, Aguado JM, Merino P, Lora-Pablos D, Guinea J, Martín-Dávila P, Cuenca-Estrella M, Almirante B.

Antimicrob Agents Chemother. 2016 May 23;60(6):3291-300. doi: 10.1128/AAC.00195-16. Print 2016 Jun.

Supplemental Content

Support Center